[Home]   [Full version]  

Brain's messengers could be regulated, researchers find

Sep 17 ,Medicine & Health



Full size image
Researchers at MIT's Picower Institute for Learning and Memory have found that tiny, spontaneous releases of the brain's primary chemical messengers can be regulated, potentially giving scientists unprecedented control over how the brain is wired.

The work, reported in the Sept. 16 early online edition of Nature Neuroscience, could lead to a better understanding of neurological diseases like schizophrenia.

Sputtering electrical activity--like a firecracker's leftover sparks after a big bang--was long considered inconsequential background noise compared with the main cell-to-cell interactions underlying thought and memory.

But lead author J. Troy Littleton, Fred and Carole Middleton Associate Professor of Biology at MIT, and colleagues found that the miniscule events that follow a burst of electrical and chemical activity among neurons are far more important that previously thought. A breakdown in this molecular mechanism could be the culprit in schizophrenia and other neurological diseases, the authors reported.

Neurons communicate with one another through chemical junctions called synapses. Key to the system are complexins. These small proteins play a role in the release of the brain's chemical messengers, or neurotransmitters, during synaptic cell-to-cell signaling.

To figure out exactly how complexins work, Littleton created the first genetically engineered mutant--in this case, a fruit fly--that produces no complexins at all.

There are two sides to synaptic transmission--pre-synaptic and post-synaptic. When an electrical nerve impulse zaps the pre-synaptic side, it triggers lightning-fast events that release neurotransmitters. This activates the post-synaptic cell. Mission accomplished: The foundation of a memory is formed.

The neurotransmitters are like racehorses. They champ at the bit until they get the signal to dash toward the finish line. On the pre-synaptic side, small compartments, or vesicles, containing neurotransmitters are the starting block, and complexins are the gatekeepers that prevent the neurotransmitters from releasing prematurely.

After a big burst of electrical activity sends out a flood of neurotransmitters, a few vesicles still produce some neurotransmitter. The MIT work explains the molecular machinery behind these "minis," which can occur for a few minutes after the big event. Without complexin as a gatekeeper, minis occur unchecked, leading to massive rewiring and synaptic growth.

"This spontaneous release in the brain is not only important for signaling, it can trigger synaptic growth," Littleton said. "What's really exciting is that complexin's activity may be regulated. If we can regulate this machinery, we may be able to promote synaptic growth and potentially allow targeted rewiring in areas of the brain affected in various neurological diseases."

Littleton also holds an appointment in MIT's Department of Brain and Cognitive Sciences.

Biology graduate student Sarah N. Huntwork coauthored the Nature Neuroscience paper.

Source: MIT

Related stories:

Meth addiction mechanism discovered
Researchers have identified, for the first time, long-term changes in the brain circuitry of methamphetamine-addicted mice that can explain why the craving of addiction is so stubborn and long-lived. The research could lead to more effective treatments for addiction to methamphetamine and related drugs.
Study suggests new treatments for Huntington's disease
Working with fruit flies, researchers have discovered a new mechanism by which the abnormal protein in Huntington’s disease causes neurodegeneration. They have also manipulated the flies to successfully suppress that neurodegeneration, which they said suggests potential treatments to delay the onset and progression of the disease in humans.
Neurotransmitters in biopolymers stimulate nerve regeneration
Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
Evidence found for novel brain cell communication
An article published today, July 16, 2007, in Proceedings of the National Academy of Sciences provides strong evidence for a novel type of communication between nerve cells in the brain. The findings may have relevance for the prevention and treatment of epilepsy, and possibly in the exploration of other aspects of brain functions, from creative thought processes to mental illnesses such as schizophrenia.
When nerve cells can’t make contact
Using an animal model, brain researchers in Göttingen have examined the effects of mutations that cause autism in humans. These are mutations in the genes which carry the building instructions for proteins in the neuroligin family. The study published in the scientific journal Neuron (September 21, 2006) shows that neuroligins ensure that signal transmission between nerve cells functions. In the brain of genetically altered mice without neuroligins, the contact points at which the nerve cells communicate, the synapses, do not mature. The researchers assume that similar malfunctions are experienced by autistic patients.
High-Resolution Light Microscope Reveals the Fundamental Mechanisms of Nerve Communication
The development of STED microscopy has allowed researchers at the Max-Planck Institute for Biophysical Chemistry to image, for the first time, proteins from single synaptic vesicles, answering long-standing questions of neurocommunication (Nature, 13th April 2006). In a simultaneous publication (Science Express, 13th April 2006), STED microscopy revealed the spatial distribution of the bruchpilot protein and aided neurobiologists from the European Neuroscience Institute and the University of Würzburg in understanding the protein’s central role in the formation of active synaptic zones.
Prostate cancer patients undergoing hormone therapy may experience cognitive effects
A recent review of the literature has found that hormone deprivation therapy, a commonly used treatment for prostate cancer, may have subtle adverse effects on cognition in patients-- such as in the ability to recall and concentrate. Published in the September 1, 2008 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that clinicians and patients should be aware of these potential effects and watch closely for their appearance.
Probing Question: Fishhooks of addiction
When the American writer Theodore Roethke taught at Penn State from 1936 to 1943, he was known for three things: being a good poet, coaching the men’s tennis team, and falling down drunk, perhaps the latter more than the former. Roethke, a brilliant and tortured man, knew well the seduction of drink and the agony of addiction. In his poem “Journey Into the Interior,” Roethke writes, “In the long journey out of the self, / There are many detours, washed-out interrupted raw places / Where the shale slides dangerously / And the back wheels hang almost over the edge / At the sudden veering, the moment of turning.”

News discussion:

Brain Control... ? in Medicine & Health news

[Home]   [Full version]